MustGrow Financial Statements From 2010 to 2025

Stocks . Canada . 
Stock . MustGrow Biologics Corp
MGRO Stock   0.65  0.02  2.99%   
MustGrow Biologics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing MustGrow Biologics' valuation are provided below:
Gross Profit
932.9 K
Profit Margin
(0.85)
Market Capitalization
39.4 M
Enterprise Value Revenue
4.8727
Revenue
7.5 M
There are over one hundred six available fundamental ratios for MustGrow Biologics, which can be analyzed over time and compared to other ratios. All traders should should check MustGrow Biologics' last-minute fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Market Cap is likely to climb to about 117.9 M in 2025. Enterprise Value is likely to climb to about 113.4 M in 2025

MustGrow Biologics Total Revenue

378,117

Check MustGrow Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MustGrow Biologics' main balance sheet or income statement drivers, such as Net Interest Income of 212.5 K, Interest Expense of 0.0 or Selling General Administrative of 3.7 M, as well as many indicators such as Price To Sales Ratio of 142, Dividend Yield of 0.0 or PTB Ratio of 28.72. MustGrow financial statements analysis is a perfect complement when working with MustGrow Biologics Valuation or Volatility modules.
  
This module can also supplement various MustGrow Biologics Technical models . Check out the analysis of MustGrow Biologics Correlation against competitors.

MustGrow Biologics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Accounts Payable134.6 K166.6 K117.5 K
Slightly volatile
Total Assets7.2 M5.4 M4.6 M
Slightly volatile
Total Current Liabilities1.5 M2.9 M742.4 K
Slightly volatile
Total Stockholder Equity3.8 M2.2 M3.2 M
Slightly volatile
Cash4.8 M3 M4.2 M
Slightly volatile
Long Term Debt118.3 K124.5 K548.9 K
Slightly volatile
Common Stock Shares Outstanding53 M51.6 M43.7 M
Slightly volatile
Non Current Liabilities Total308 K350.1 K574.9 K
Slightly volatile
Total Liabilities1.9 M3.2 M1.3 M
Slightly volatile
Net Invested Capital4.4 M2.7 M4 M
Slightly volatile
Short and Long Term Debt437.6 K393.5 K280.2 K
Slightly volatile
Total Current Assets5.1 M4.7 M4.4 M
Slightly volatile
Capital Stock24.5 M25.3 M17.3 M
Slightly volatile
Net Working Capital1.7 M1.8 M3.6 M
Pretty Stable

MustGrow Biologics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative3.7 M3.8 M3.1 M
Slightly volatile
Research Development597.2 K773.9 K300.3 K
Slightly volatile
Total Operating Expenses5.1 M5.5 M3.9 M
Slightly volatile
Interest Income143.2 K202.4 K43.8 K
Slightly volatile
Gross Profit285.7 K300.8 K4.2 M
Slightly volatile

MustGrow Biologics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow2.8 M3 M4.6 M
Pretty Stable
Stock Based Compensation1.1 M1.5 M877.7 K
Slightly volatile
Change In Working Capital184.3 K108.9 K91.9 K
Slightly volatile
Begin Period Cash Flow6.8 M6.8 M4.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio14214914.3 K
Very volatile
Days Sales Outstanding89.5494.25011.3 K
Pretty Stable
Average Payables1.3 M1.3 M466.3 K
Slightly volatile
Stock Based Compensation To Revenue0.250.2626.248
Pretty Stable
EV To Sales13614314.2 K
Very volatile
Inventory Turnover0.05440.06120.0667
Slightly volatile
Days Of Inventory On Hand4.3 K4.8 K5.3 K
Slightly volatile
Payables Turnover0.03690.03891.3169
Slightly volatile
Sales General And Administrative To Revenue7.998.4141155
Pretty Stable
Average Inventory572.1 K643.6 K701.7 K
Slightly volatile
Research And Ddevelopement To Revenue1.851.944314.2744
Slightly volatile
Capex To Revenue0.00.00.0
Slightly volatile
Cash Per Share0.06660.05810.0581
Slightly volatile
Days Payables Outstanding9.9 K9.4 K1.4 K
Slightly volatile
Income Quality0.770.73190.7944
Slightly volatile
Intangibles To Total Assets0.0880.09560.1045
Slightly volatile
Current Ratio1.531.60892.7047
Slightly volatile
Receivables Turnover7.263.87274.1003
Slightly volatile
Average Receivables46.1 K43.9 K25 K
Slightly volatile
Revenue Per Share0.01180.00770.0074
Slightly volatile
Interest Debt Per Share0.00950.010.0275
Slightly volatile
Debt To Assets0.09090.09568.6808
Pretty Stable
Operating Cycle5.7 K5.5 K2 K
Slightly volatile
Days Of Payables Outstanding9.9 K9.4 K1.4 K
Slightly volatile
Ebt Per Ebit1.860.95591.4604
Very volatile
Quick Ratio1.061.11522.6445
Slightly volatile
Net Income Per E B T0.580.910.5917
Slightly volatile
Cash Ratio0.981.03492.5898
Slightly volatile
Days Of Inventory Outstanding4.3 K4.8 K5.3 K
Slightly volatile
Days Of Sales Outstanding89.5494.25011.3 K
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.81.00.9875
Slightly volatile
Fixed Asset Turnover1.421.991.8204
Slightly volatile
Debt Ratio0.09090.09568.6808
Pretty Stable
Price Sales Ratio14214914.3 K
Very volatile
Asset Turnover0.110.07350.1027
Pretty Stable

MustGrow Biologics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap117.9 M59.3 M94.4 M
Slightly volatile
Enterprise Value113.4 M56.9 M91.9 M
Slightly volatile

About MustGrow Biologics Financial Statements

MustGrow Biologics investors use historical fundamental indicators, such as MustGrow Biologics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MustGrow Biologics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue398 K378.1 K
Cost Of Revenue97.3 K53.5 K
Stock Based Compensation To Revenue 0.26  0.25 
Sales General And Administrative To Revenue 8.41  7.99 
Research And Ddevelopement To Revenue 1.94  1.85 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(12.85)(13.49)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for MustGrow Stock Analysis

When running MustGrow Biologics' price analysis, check to measure MustGrow Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MustGrow Biologics is operating at the current time. Most of MustGrow Biologics' value examination focuses on studying past and present price action to predict the probability of MustGrow Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MustGrow Biologics' price. Additionally, you may evaluate how the addition of MustGrow Biologics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY